Thursday, April 18, 2024 6:17:41 PM
You will have to excuse stockman's ignorance on the subject, but he does have the right to express his opinion, as you do.
My guess is he looked at the numbers below and come to that conclusion. Silly him.
OS number in context.
08/24/2018 Reverse 1:100
03/27/2020 Reverse 1:10000
AS increase or reverse split should occur in 2023 at current rate of dilution.
March 2023 AS announced to increase to 7 Billion
Mid April. 400k. ( following 10000:1 RS was 4 billion)
Mid May. 2.3 Million
Mid June 17.2 Million
Mid July 152 million (Restated 196 Million)
Mid August 446 million
End September 843 Million
October 1.504 Billion
November 1.889 Billion
December 2.326 Billion
Dilution stopped following a deal with the toxic dilutors
Feb 2021 OS has continued to rise, and is now 2.9 billion
Mar 2021 3.229 Billion
Apr 2021 3.545 Billion
May / June No Change
July 2021 3.853 Billion
Aug 2021 3.967 Billion
Sep 2021 4.03 Billion
Oct 2021 4.33 Billion
Nov 2021 4.38 Billion
Dec 2021 4.43 Billion
Jan 2022 4.63 Billion
Feb 2022 4.73 Billion
March 2022 - No Change
April 2022 4.83 Billion
May 2022 4.86 Billion
June 2022 4.94 Billion
July 2022 4.99 Billion AS raised to 6 Billion
Aug 2022 5.06 Billion
Sep 2022 5.08 Billion
Oct 2022 5.15 Billion
Nov 2022 5.27 Billion
Dev 2022 5.36 Billion
Jan 2023 5.50 Billion
Feb 2023 5.83 Billion
March 2023 5.89 Billion
Apr 26 2023 6 Billion
May 18 2023 6.05 Billion
May 31 2023 6.1 Billion
June 6 20236.2 Billion
June 23 2023 6.4 Billion
July 11 2023 6.5 Billion
July 28 2023 6.7 Billion
Aug 29 2023 7 Billion
Sept 12 2023 7.1 Billion AS raised to 10 Billion
Oct 10 2023 7.2 Billion
Oct 25 2023 7.4 Billion
Nov 11 2023 7.5 Billion
Nov 29 2023 7.7 Billion
Dec 13 2023 8.1 Billion
Dec 29 2023 8.3 Billion
Jan 18 2024 8.6 Billion
Feb 1 2024 8.9 Billion
Feb 16 2024 9.2 Billion
Mar 5 2024 9.505 Billion
Mar 19 2024 9.757 Billion
Apr 5 2024 9.949 Billion AS being raised to 12.5 billion
Recent AITX News
- Shares Moving Up For AI SAAS Firm on News of an Initial Order • AllPennyStocks.com • 04/11/2024 03:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:04:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:08:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 11:01:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 11:09:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:07:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 11:05:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 11:02:46 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/07/2024 05:15:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 11:05:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 11:02:25 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2024 09:21:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 11:03:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 11:01:53 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/19/2024 09:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 11:04:22 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 08:59:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:05:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 11:02:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 11:03:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 11:03:10 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/12/2023 08:58:16 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM